Single Use Device Endoscopy for the Diagnosis of Acute Bacterial Rhinosinusitis in Primary Care

Last updated: January 13, 2020
Sponsor: Dominik Glinz
Overall Status: Active - Recruiting

Phase

N/A

Condition

Sinusitis

Treatment

N/A

Clinical Study ID

NCT03766568
Sinus-Endo Study
  • Ages > 18
  • All Genders

Study Summary

This is a pilot study to assess the first time use of the JGG endoscope® in humans and in primary care. The JGG endoscope® is attached to a Heine® otoscope and allows to inspect and to collect samples from the middle meatus of the sinus. The JGG endoscope® is sterile packaged, for one way use and disposable.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Adults patients aged ≥18 years, with acute rhinosinusitis

  • Duration: worsening of symptoms after 5 days after onset of symptoms or if symptomspersist for more than 10 days, but no longer than 28 days. In addition, Criteria 1 and 2 must be fulfilled. Criteria 1 for acute rhinosinusitis:

[Nasal blockage/obstruction/congestion OR Nasal Discharge (anterior/ posterior nasal drip)]AND [Facial pain/ pressure OR Reduction or loss of smell] Criteria 2 for acute bacterial rhinosinusitis Indicated by the presence of at least one of the following symptoms:

  • discoloured discharge (unilateral predominance)

  • severe local pain (unilateral predominance)

  • fever, that is >38°C

  • elevated inflammatory markers (CRP)

  • 'double sickening' whereby the patient's condition deteriorates.

Exclusion

Exclusion Criteria:

  • Not being able to provide written informed consent in German (due to any mental orintellectual problem or other reasons)

  • Not being available for follow-up

  • Previous participation in Sinus-Endo study

  • Use of antibiotic the last 4 weeks

  • Known pathology or malformation of the sinuses or nasal cavity (like polyposis)

  • Known pregnancy

  • Allergic reactions to local anaesthetics

  • Anticoagulation therapy

Study Design

Total Participants: 60
Study Start date:
December 17, 2018
Estimated Completion Date:
September 30, 2020

Study Description

Acute rhinosinusitis is one of the most common reasons for consultations and antibiotic prescriptions in primary care although the condition is primarily of viral origin. The main reason for antibiotic overuse in acute rhinosinusitis is the lack of diagnostic tests of sufficient accuracy to confirm or rule out the diagnosis of acute bacterial rhinosinusitis (ABRS).

The gold standard for the diagnosis of ABRS is a bacterial culture from sinus maxillary puncture. This procedure is painful, prone to complications and only done in selected patients by oto-rhino-laryngology (ORL) specialists or for research purposes. Therefore, endoscopy of the middle meatus and collection of diagnostic material from the ostium draining the sinus is the diagnostic method of choice for ABRS and routinely used by ORL specialists in house and elsewhere. In patients with clinical symptoms of sufficient severity and duration (typically 5-10 days) for ABRS, endoscopy has a sensitivity of 85.7% (95% confidence interval, 56.2-97.5), specificity of 90.6% (73.8-97.5), positive predictive value of 80% (51.4-94.7), negative predictive value of 93.5% (77.2-98.9) for culture proven ABRS when compared with cultures gained from sinus puncture. Because of high upfront costs and logistical reason (disinfection) endoscopy is not used in general practice or internal medicine.

Dr. Jens G. Hansen has developed the disposable JGG endoscope® (JGG stands for the surnames of the inventor and his wife) which can be attached to the new generation of Heine® otoscopes with a LED light source that allows the inspection of the ostium in the middle meatus and collection of material for bacterial culture for the diagnosis of ABRS in primary care. After local anaesthesiology of the cavum nasi a sample material for cultures can be gained (earliest 10 min after local anaesthesia). The diagnostic procedure poses patients at minimal risk for complications and is of very little and short-termed discomfort.

In a pilot study the investigators would like to test the JGG endoscope® in 60 patients with suspected acute bacterial rhinosinusitis in the ORL unit of the University Hospital Basel and selected general practices that collaborate with the Centre for Primary Health Care of the University of Basel.

Objectives:

  1. To assess the feasibility of visualization and sample collection from the middle meatus with the JGG endoscope® in patients with clinically diagnosed acute bacterial rhinosinusitis in Swiss primary care setting

  2. to investigate whether the JGG endoscope® supports the decision of antibiotic prescribing

  3. to assess patients' and physicians' acceptability of the examination with the JGG endoscope®

  4. to investigate the prevalence of culture proven acute bacterial rhinosinusitis from samples of the middle meatus by the JGG endoscope® in patients with clinically diagnosed acute rhinosinusitis

  5. to investigate the number of patients with acute rhinosinusitis diagnosed by the JGG endoscope® with any and/or deferred antibiotic prescriptions

  6. to investigate the days with restrictions and symptoms in patients with acute rhinosinusitis with positive and negative bacterial cultures diagnosed by the JGG endoscope®

  7. to investigate any serious adverse event related to the JGG endoscope®.

Design Prospective observational cohort study (single arm study)

Connect with a study center

  • Praxis Vogt

    Liestal, BL 4410
    Switzerland

    Active - Recruiting

  • Hausarztpraxis Muttenz AG

    Muttenz, BL 4132
    Switzerland

    Active - Recruiting

  • mediX toujours Pratteln

    Pratteln, BL 4133
    Switzerland

    Active - Recruiting

  • HNO Klinik, University Hospital Basel

    Basel, BS 4031
    Switzerland

    Active - Recruiting

  • Praxis Hammer

    Basel, BS 4057
    Switzerland

    Site Not Available

  • mediX toujours Basel

    Basel, BS 4051
    Switzerland

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.